P51 Randomised, Single-Centre, Phase 2 Trial of Nimotuzumab Plus Cisplatin and S-1 As First-Line Therapy in Patients with Advanced Gastric Cancer
European journal of cancer Supplement(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
European journal of cancer Supplement(2011)